Baxter International Inc. is set to attend a symposium in Vienna, Austria, where they will present their new Hemopatch sealing hemostat, a room-temperature collagen pad designed for hemostasis and sealing in both open and minimally invasive surgical procedures. The event marks a significant milestone in the product's development, shaped by a decade-long collaboration with experts and feedback from surgeons.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baxter International Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: EN48592) on August 18, 2025, and is solely responsible for the information contained therein.